Univercells Technologies Debuts the scale-X™ Nitro Controller to Expand Access to Large-Scale Viral and Advanced Therapy Manufacturing
Univercells Technologies, a Donaldson Life Sciences business and global provider of bioprocessing solutions, announced the launch of the scale-X™ nitro controller, the latest addition to its scale-X fixed-bed bioreactor portfolio. Designed to operate both the 200 and 600 m² scale-X nitro bioreactors, the new controller becomes part of the scale-X platform for a cost-effective, low-footprint and user-friendly solution for large-scale viral and advanced therapy manufacturing. The controller delivers high productivity while enabling rapid scalability from R&D to commercial production in just eight months.
